Inventor · disambiguated record
Leigh Zawel
Also filed as: ZAWEL LEIGH · ZAWEL LEIGH SCOTT
17 granted patents·18 pending applications·161 citations·filing 1998–2022
92Inventor score
Top patents by PatentIndex Score
35 records- 0196US7419975B2Organic compoundsNOVARTIS AG·Filed 2005·Granted Sep 2, 2008·80 cites·10 claims
- 0291US8552003B2(S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their usesCHAREST MARK G·Filed 2007·Granted Oct 8, 2013·30 cites·4 claims
- 0390US8546336B2SMAC peptidometics useful as IAP inhibitorsCHEN ZHUOLIANG·Filed 2012·Granted Oct 1, 2013·15 cites·3 claims
- 0486US7989441B2Organic compoundsNOVARTIS AG·Filed 2006·Granted Aug 2, 2011·8 cites·8 claims
- 0585US8044209B2Pyrrolydine derivatives as IAP inhibitorsNOVARTIS AG·Filed 2007·Granted Oct 25, 2011·8 cites·10 claims
- 0684US11382905B2Immunomodulation by IAP inhibitorsNOVARTIS AG·Filed 2020·Granted Jul 12, 2022·1 cites·4 claims
- 0779US10786491B2Immunomodulation by IAP inhibitorsNOVARTIS AG·Filed 2017·Granted Sep 29, 2020·1 cites·6 claims
- 0876US8492429B2Combination of IAP inhibitors and FLT3 inhibitorsGRIFFIN JAMES DOUGLAS·Filed 2007·Granted Jul 23, 2013·3 cites·6 claims
- 0974US2022296581A1Immunomodulation by IAP InhibitorsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1066US8207183B2Inhibitors of IAPPALERMO MARK G·Filed 2011·Granted Jun 26, 2012·1 cites·15 claims
- 1160US8906936B2Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereofNOVARTIS AG·Filed 2013·Granted Dec 9, 2014·0 cites·6 claims
- 1259US9750729B2Immunomodulation by IAP inhibitorsZAWEL LEIGH·Filed 2009·Granted Sep 5, 2017·0 cites·19 claims
- 1357US2009005411A1Combinations of Organic CompoundsNOVARTIC AG·Filed 2006·Application pending·0 cites
- 1456US8048886B2Substituted pyrazine-3-one-derivatives as IAP inhibitorsNOVARTIS AG·Filed 2007·Granted Nov 1, 2011·0 cites·4 claims
- 1555US2014024687A1Combinations of Vascular Disrupting Agents with Inhibitor of Apoptosis Proteins AntagonistsCONWAY COLLEEN ANN·Filed 2013·Application pending·0 cites
- 1654US2023372346A1Treatment regimens for exon-20 insertion mutant egfr cancersCULLINAN PEARL CORP·Filed 2021·Application pending·0 cites
- 1754US2014004101A1Smac peptidometics useful as iap inhibitorsCHEN ZHUOLIANG·Filed 2013·Application pending·0 cites
- 1853US2006281078A1Human fast-1 geneZHOU SHIBIN·Filed 2001·Application pending·0 cites
- 1953US2013085153A1Combination of an iap inhibitor and a taxane for the treatment of a proliferative diseaseJENSEN MICHAEL RUGAARD·Filed 2012·Application pending·0 cites
- 2052US2010324083A1Combinations of Organic CompoundsNOVARTIS AG·Filed 2010·Application pending·0 cites
- 2151US6110738AHuman fast-1 geneUNIV JOHNS HOPKINS·Filed 1998·Granted Aug 29, 2000·4 cites·12 claims
- 2250US8058272B2Organic compoundsCHEN ZHUOLIANG·Filed 2007·Granted Nov 15, 2011·0 cites·2 claims
- 2350US2011281845A1Organic compoundsCHEN ZHUOLIANG·Filed 2011·Application pending·0 cites
- 2449US8338440B2Inhibitors of IAPPALERMO MARK G·Filed 2012·Granted Dec 25, 2012·0 cites·17 claims
- 2548US6100032AHuman Smad3 and Smad4 are sequence-specific transcription activatorsUNIV JOHNS HOPKINS·Filed 1998·Granted Aug 8, 2000·10 cites·57 claims
- 2648US2006128632A1Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)SHARMA SUSHIL K·Filed 2003·Application pending·0 cites
- 2748US2006052311A1Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (IAP)SHARMA SUSHIL K·Filed 2005·Application pending·0 cites
- 2847US6225441B1Human fast-1 proteinUNIV JOHNS HOPKINS·Filed 2000·Granted May 1, 2001·0 cites·10 claims
- 2947US2010076013A1Methods of TreatmentNOVARTIS AG·Filed 2007·Application pending·0 cites
- 3047US2012129895A1Methods of treatmentCONWAY COLLEEN·Filed 2010·Application pending·0 cites
- 3145US2011319614A1Organic CompoundsCHEN ZHUOLIANG·Filed 2011·Application pending·0 cites
- 3243US2011251134A1Combination of (a) a dna toposomerase inhibitor and (b) an iap inhibitorZAWEL LEIGH·Filed 2005·Application pending·0 cites
- 3342US2015051227A1Predictive biomarker useful for cancer therapy mediated by a cdk inhibitorMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 3440US2010316573A1Organic CompoundsGAITHER LARRY ALEXANDER·Filed 2007·Application pending·0 cites
- 3533US2012196793A1Biomarkers for iap inhibitor compoundsFIRESTONE BRANT G·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Leigh Zawel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →